DZD-6008

N/A

Report date: 2025/06/05 20:00:13
NME

Base Information

Drug NameDZD-6008
Drug Alias NameDZD6008DZD-6008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor inhibitors
TargetsEpidermal growth factor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesDizal (Jiangsu) Pharmaceutical Co LtdDizal (Shanghai) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A